TRIESENCE

This brand name is authorized in Canada, Spain, Finland, United States

Active ingredients

The drug TRIESENCE contains one active pharmaceutical ingredient (API):

1 Triamcinolone UNII F446C597KA - TRIAMCINOLONE ACETONIDE

Triamcinolone acetonide is a more potent derivative of triamcinolone and is approximately 8 times more potent than prednisone. Although the precise mechanism of corticosteroid anti-allergic action is unknown, corticosteroids are very effective in the treatment of allergic diseases in man. Also, local injections are thought to have an anti-inflammatory effect. Read about Triamcinolone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01BA05	Triamcinolone	S Sensory organs → S01 Ophthalmologicals → S01B Antiinflammatory agents → S01BA Corticosteroids, plain
Discover more medicines within S01BA05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02368676
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 74673
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 412915
Country: US	FDA, National Drug Code	Identifier(s): 0065-0543